Xeljanz Xr 63539-0502
Generic: Tofacitinib
Product NDC
63539-0502- Manufacturer
- U.s. Pharmaceuticals
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- January 21, 2020
- Listing Expires
- December 31, 2027
- Application
- NDA208246
Need to source Xeljanz Xr? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tofacitinib Citrate | 22 mg/1 |
Drug Class
Janus Kinase Inhibitor [EPC]Janus Kinase Inhibitors [MoA]
Packaging Options(1)
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63539-502-30)